SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant downward pressure following a launch anomaly where Blue Origin's New Glenn rocket failed to place a BlueBird satellite into the correct orbit. While the community is actively debating the impact of this setback on launch timelines and partner reliability, investors are divided between capitalizing on the dip as an overreaction to an insured event and concerns regarding execution risks versus established industry competitors.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing high volatility driven by a short-seller report that has triggered intense community debate regarding the company's tax status and growth narrative. Investors are actively discussing the firm's response to these claims, alongside optimistic sentiment surrounding its recent technological partnerships and upcoming strategic shifts.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as investors react to a strategic $2.8 billion acquisition of Brazil's Serra Verde Group, a move designed to secure critical supply chain independence for magnetic rare earths. While the community is actively debating the short-term impact of the stock-and-cash dilution, broader sentiment remains focused on the company's long-term potential as a U.S.-backed infrastructure play for the defense, EV, and AI sectors.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing massive social media buzz following an executive order that fast-tracks research for psychedelic therapies, with the community highlighting its focus on Ibogaine as a primary catalyst. Investors are actively debating the stock's potential for a short squeeze due to its low float and limited share availability, as strong sentiment clashes with warnings about the inherent volatility of micro-cap biotech trading.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing intense market volatility as investors weigh the potential of its AI-driven enterprise tools against fears that generative AI could disrupt its established creative software moat. The stock is currently experiencing significant downward pressure as the community debates whether the recent sell-off represents an irrational disconnect from elite fundamentals or a structural shift in the software landscape.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors focus on its potential as a breakthrough in cancer immunotherapy, bolstered by positive clinical trial data and recent analyst coverage projecting significant peak sales. The community is actively debating the company's valuation relative to its pipeline, with bullish sentiment driven by anticipation of upcoming prostate cancer data reveals and the possibility of strategic partnerships or buyout interest.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

ATAI Life Sciences N.V.

ATAI Life Sciences is trending as shares rally following a new executive order signed by the President to accelerate the review and funding of psychedelic drug research for mental health treatments. The community is actively discussing the potential for a massive repricing or buyout, with many traders closely watching for institutional activity and the upcoming Phase 3 clinical trial developments.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors react to a significant expansion of its partnership with NVIDIA to power safety-critical edge AI systems for robotics and industrial applications. The community is actively discussing the stock's potential for a broader valuation reset, with many highlighting the companys transition from a legacy name to a vital infrastructure play in the physical AI sector.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is facing heightened volatility and selling pressure as investors weigh mixed earnings results against concerns regarding management's strategic vision and potential deal uncertainty. The community is actively debating the company's long-term debt position and the sustainability of its business model, while some traders closely monitor technical indicators for signs of a reversal or a possible breakout.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways (CMPS) and peers in the psychedelic biotech space are surging following an executive order from President Trump designed to accelerate research and FDA review pathways for mental health treatments. While the sector is experiencing high-conviction momentum and institutional interest, community discourse remains divided between those betting on long-term clinical success and those wary of volatility and the potential for short-term speculative 'pump and dump' dynamics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Abivax (NASDAQ:ABVX) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen raised Abivax from a "sell" rating to a "hold" rating in a research note on Saturday...

Tudor Investment Corp ET AL Buys New Position in Abivax SA Sponsored ADR $ABVX

Tudor Investment Corp ET AL bought a new position in shares of Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) during the third quarter, according to its most recent 13F filing with the...

Stock Futures Slide As Doubts Over Ceasefire Send Oil Higher

Stock Futures Slide As Doubts Over Ceasefire Send Oil Higher Stocks resumed their drop and oil erased about a third of its Wednesday drop as traders watched the fragile US-Iran ceasefire shatter by...

Harbor Capital Advisors Inc. Takes Position in Abivax SA Sponsored ADR $ABVX

Harbor Capital Advisors Inc. bought a new position in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 8,849 shares of the company's stock, valued a...

Aberdeen Group plc Trims Stock Position in Abivax SA Sponsored ADR $ABVX

Aberdeen Group plc lessened its stake in shares of Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) by 45.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities...

Banque Pictet & Cie SA Purchases Shares of 15,348 Abivax SA Sponsored ADR $ABVX

Banque Pictet & Cie SA purchased a new position in shares of Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with...

Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of Abivax SA Sponsored ADR (NASDAQ:ABVX - Get Free Report) have been given a consensus rating of "Moderate Buy" by the fourteen analysts that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, twelve have ass...

Tudor Investment Corp ET AL Acquires New Position in Abivax SA Sponsored ADR $ABVX

Tudor Investment Corp ET AL acquired a new stake in shares of Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with...

Promising Biotech Stocks To Add to Your Watchlist - March 27th

Danaher, Onconetix, Moderna, argenex, Vertex Pharmaceuticals, Abivax, and Rocket Pharmaceuticals are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...

Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears

Abivax plans fundraising after June trial data as CEO signals no urgency to sell amid takeover speculation and strong stock momentum.read more...

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.93	--	--	N/A
Q4 '25	-$1.35	--	--	N/A
Q3 '25	-$1.85	-$2.47	-33.29%	MISSED
Q2 '25	-$0.93	-$1.38	-48.09%	MISSED
Q1 '25	-$0.76	--	--	N/A

ABVX
Abivax - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest ABVX News

ABVXAbivax - ADR